Added to YB: 2025-11-18
Pitch date: 2025-11-14
TEM [neutral]
Tempus AI, Inc.
-30.37%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$67.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
TEM | Tempus AI Q3 2025 Financial Report Highlights
TEM (earnings): Rev +85% to $334M, first positive adj EBITDA $1.5M (vs $4M est), Q4 guidance $20M EBITDA. Genomics +117%, Insights bookings +38%. Gross margin 63.6% (+400bps). Acquired Paige for multimodal AI, 3 FDA approvals. At $68 vs DCF $55-65, overvalued despite strong execution.
Read full article (9 min)